Zepteon Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
4

- Latest Deal Type
-
2ndary - Private
Zepteon General Information
Description
Developer of chromatography resins designed for the separation of non-fucosylated antibodies. The company develops chromatography resins that are capable of generating highly potent antiviral biologic therapies as well as can be used analytically for rapid analysis of bioreactor conditions, enabling physicians to make biosimilar antibodies with targeted non fucose levels.
Contact Information
Website
www.zepteon.comCorporate Office
- 42 Chauncy Street
- Suite 10A
- Boston, MA 02111-2308
- United States
Corporate Office
- 42 Chauncy Street
- Suite 10A
- Boston, MA 02111-2308
- United States
Zepteon Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Secondary Transaction - Private | Completed | Generating Revenue | ||||
1. Angel (individual) | 09-Apr-2015 | Completed | Startup |
Zepteon Comparisons
Industry
Financing
Details
Zepteon Competitors (14)
One of Zepteon’s 14 competitors is Cellectis, a Formerly VC-backed company based in Paris, France.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Cellectis | Formerly VC-backed | Paris, France | ||||
Meridian Bioscience | Private Equity-Backed | Cincinnati, OH | ||||
Svar | Venture Capital-Backed | Malmo, Sweden | ||||
Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
Imperial Life Sciences | Corporation | Gurugram, India |
Zepteon Patents
Zepteon Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20130084648-A1 | Polypeptide separation methods | Active | 20-Jul-2011 | ||
AU-2012283858-A1 | Polypeptide separation methods | Active | 20-Jul-2011 | ||
US-10221210-B2 | Polypeptide separation methods | Active | 20-Jul-2011 | ||
AU-2012283858-B2 | Polypeptide separation methods | Inactive | 20-Jul-2011 | ||
CA-2842559-A1 | Polypeptide separation methods | Inactive | 20-Jul-2011 | C07K1/22 |
Zepteon Signals
Zepteon FAQs
-
When was Zepteon founded?
Zepteon was founded in 2012.
-
Where is Zepteon headquartered?
Zepteon is headquartered in Boston, MA.
-
What is the size of Zepteon?
Zepteon has 4 total employees.
-
What industry is Zepteon in?
Zepteon’s primary industry is Surgical Devices.
-
Is Zepteon a private or public company?
Zepteon is a Private company.
-
What is Zepteon’s current revenue?
The current revenue for Zepteon is
. -
How much funding has Zepteon raised over time?
Zepteon has raised $210K.
-
Who are Zepteon’s competitors?
Cellectis, Meridian Bioscience, Svar, Intellia Therapeutics, and Imperial Life Sciences are some of the 14 competitors of Zepteon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »